MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2021

    Safinamide Improves Pain in Parkinson´s Disease. Results from the SAFINONMOTOR Study.

    R. Yáñez, C. Labandeira, M. Cimas Hernando, I. Cabo, J. Paz González, M. Alonso Losada, M. González Palmás, C. Martínez, D. Santos García (Ourense, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on pain in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    Obstructive sleep apnea and other vascular risk factors’ impact on Non-motor Symptoms in Parkinson’s Disease

    B. Meira, M. Fernandes, M. Salavisa, M. Saraiva, L. Conceiçao, C. Borbinha, F. Ladeira, JP. Marto, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

    Objective: To investigate the relationship between vascular comorbidity and non-motor symptoms in Parkinson’s Disease (PD) patients. Background: Previous studies suggested a significant association between the…
  • MDS Virtual Congress 2021

    The satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s disease

    A. Sauerbier, P. Bachon, L. Ambrosio, P. Leohrer, A. Rizos, S. Jost, A. Gronostay, A. Konitsioti, M. Barbe, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)

    Objective: To explore a new rating tool to assess satisfaction with life and treatment (SLTS-7) in a PD population. Background: The satisfaction with life and in…
  • MDS Virtual Congress 2021

    Fatigue in patients with progressive supranuclear palsy

    JH. Ahn, J. Song, I. Choi, DY. Lee, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate prevalence and clinical impact of fatigue in the patients with progressive supranuclear palsy Background: Fatigue is a common and disabling non-motor symptom…
  • MDS Virtual Congress 2021

    Physical activity (PA), patient reported outcomes and quality of life in Parkinson’s disease( PD)

    J. Morley, I. Subramanian, J. Farahnik, L. Mischley (Philadelphia, USA)

    Objective: To examine the association between PA, motor and non-motor symptoms (NMS) and quality of life (QoL) in PD using a validated web-based survey Background:…
  • MDS Virtual Congress 2021

    Gender bias in patients with Parkinson’s disease undergoing subthalamic stimulation

    S. Jost, L. Strobel, A. Rizos, P. Loehrer, K. Ashkan, J. Evans, F. Rosenkranz, M. Barbe, G. Fink, J. Franklin, A. Sauerbier, C. Nimsky, A. Sattari, K. Ray Chaudhuri, A. Antonini, L. Timmermann, P. Martinez-Martin, M. Silverdale, E. Kalbe, V. Visser-Vandewalle, H. Dafsari (Cologne, Germany)

    Objective: To investigate whether there is a gender bias in patients with Parkinson’s disease (PD) undergoing deep brain stimulation (DBS) at a single health system…
  • MDS Virtual Congress 2021

    Determinants of exercise behavior in Parkinson’s disease patients: Self-confidence in balance and fatigue play the pivotal role.

    J. Song, WY. Shin, JH. Lim, JH. Ahn, I. Choi, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: To identify the determinants of the exercise behavior in PD patients Background: The exercise is promising treatment for Parkinson’s disease (PD) which has been…
  • MDS Virtual Congress 2021

    Maintenance of physical activity (PA) mitigates worsening of patient-reported outcomes in Parkinson’s disease (PD) during the COVID-19 pandemic

    J. Morley, I. Subramanian, J. Farahnik, L. Mischley (Philadelphia, USA)

    Objective: To examine changes in PD-patient reported outcomes during the COVID19 pandemic and the influence of changes in PA over the same period Background: Exercise interventions…
  • MDS Virtual Congress 2021

    Impact of Covid-19 on Essential Tremor and Dystonic Tremor: experience of an Italian centre

    SM. Cartella, C. Terranova, I. Arena, G. Falcone, A. Quartarone, P. Girlanda (Messina, Italy)

    Objective: To assess the impact of Covid-19 on Essential and Dystonic Tremor, with regard on non-motor symptoms, social aspects and everyday life. Background: Covid-19 had…
  • MDS Virtual Congress 2021

    Subjective cognitive complaints assessed with the cognitive domain of the Non-Motor Symptoms Scale predict longitudinal cognitive trajectory in people with Parkinson’s disease with normal cognition

    L. Batzu, DJ. van Wamelen, D. Urso, V. Leta, A. Podlewska, K. Rukavina, J. Staunton, YM. Wan, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate whether subjective cognitive complaints assessed by the Non-Motor Symptoms Scale (NMSS) are predictive of longitudinal cognitive trajectories in cognitively intact people with…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley